Abeona Therapeutics Inc Banner Image

Abeona Therapeutics Inc

  • Ticker ABEO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Abeona Therapeutics Inc Logo Image
  • 51-200 Employees
  • Based in New York City, New York
Abeona Therapeutics Inc., a biopharmaceutical company, focuses on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. The company offers MuGard, a mucoadhesive oral wound rinse for mucositis, stomatitis, aphthous ulcers, and traumatic ulcers; and ProctiGard, a mucoadhesive oral wound rinse for the treatment of rectal mucositisMore and radiation proctitis.
4.8 / 5.0 (152)

Abeona Therapeutics Inc reports have an aggregate usefulness score of 4.8 based on 152 reviews.

Abeona Therapeutics Inc

Most Recent Annual Report

Abeona Therapeutics Inc
MOST RECENT 2023 Annual Report and Form 10K

Abeona Therapeutics Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Abeona Therapeutics Inc Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!